Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03527667 · ClinicalTrials.gov registry record · NA
Incentivized Smoking Cessation for Diabetics
A NA study, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT03527667 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 19 participants.
The verdict
NCT03527667, a NA study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
This pilot study aims to test the feasibility of providing incentives to patients with T2D contingent on remote biochemical verification using a smartphone carbon monoxide (CO) monitor. The investigators will use an ecological momentary assessment (EMA) smartphone application and CO sensor to monitor urges to smoke, stressors, smoking behaviors, and to validate continuous abstinence throughout the intervention. Two different contingency management structures will be explored to investigate the length of time incentives need to be offered.
Interventions
- BEHAVIORAL Financial incentives
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-06-22 |
| Est. Completion | 2019-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03527667
The ClinicalTrials.gov registry entry for NCT03527667 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Financial incentives is the first listed.
NCT03527667 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03527667 about?
NCT03527667 is a clinical study titled "Incentivized Smoking Cessation for Diabetics". This pilot study aims to test the feasibility of providing incentives to patients with T2D contingent on remote biochemical verification using a smartphone carbon monoxide (CO) monitor. The investigators will use an ecological momentary assessment (EMA) smartphone application and CO sensor to monito...
What is the current status of trial NCT03527667?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2018-06-22. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT03527667?
The interventions under investigation include: Financial incentives (BEHAVIORAL).
Who is sponsoring clinical trial NCT03527667?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.